BB Biotech AG

SIX:BION.SW

37.4 (CHF) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CHF.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003
Revenue -199.567-351.227-396.22699.233685.238-465.753693.053-796.446659.2271,476.387937.893376.82-1.2691.57854.29373.820318.065332.66213.657193.512
Cost of Revenue 000000000000000000000
Gross Profit -199.567-351.227-396.22699.233685.238-465.753693.053-796.446659.2271,476.387937.893376.82-1.2691.57854.29373.820318.065332.66213.657193.512
Gross Profit Ratio 111111111111111101111
Reseach & Development Expenses 000000000000000000000
General & Administrative Expenses 4.3474.2596.0595.2274.6562.7283.1432.7895.4565.1124.9357.7464.5864.9625.9187.18528.949.448.218.2747.662
Selling & Marketing Expenses 1.5671.1711.2931.6131.8722.1222.2662.0380000000000000
SG&A 5.9145.437.3526.846.5284.855.4094.8275.4565.1124.9357.7464.5864.9625.9187.18528.949.448.218.2747.662
Other Expenses 01.0941.1691.1441.2110.6690.0640.7210.8751.0580.9870.94159.196142.888-5.6421.206-0.983-318.065-332.664.6446.903
Operating Expenses 6.966.5248.5217.9847.7395.5195.4735.5486.3316.175.9228.68763.782147.859.99328.39127.957-308.625-324.4512.91814.565
Operating Income -206.528-356.025-404.741691.249677.499-470.186688.122-800.909653.0751,470.769932.968370.816-65.051-146.27244.345.429-27.957626.69657.11200.739178.947
Operating Income Ratio 1.0351.0141.0220.9890.9891.010.9931.0060.9910.9960.9950.98451.262-92.6950.8160.61501.971.9750.940.925
Total Other Income Expenses Net -171.925-1.726-345.543-2.74-2.416-1.086-0.542-1.085-0.179-0.552-0.998-2.6830-0.022-6.868-0.012-237.341-329.184-338.9362.1070.555
Income Before Tax -206.528-357.751-404.741691.249677.499-471.272687.58-801.994652.8961,470.217931.97368.133-65.051-146.29437.43245.417-265.298297.506318.174202.846179.502
Income Before Tax Ratio 1.0351.0191.0220.9890.9891.0120.9921.0070.990.9960.9940.97751.262-92.7080.6890.61500.9350.9560.9490.928
Income Tax Expense 0.0790.0610.0670.0750.0680.0710.0770.0710.080.0780.1360.2990.0870.0540.8060.064-0.113-0.111-0.1810.0940.167
Net Income -206.607-357.812-404.808691.174677.431-471.343687.503-802.065652.8161,470.139931.834367.834-65.138-146.34836.62645.353-265.411297.395317.993202.752179.335
Net Income Ratio 1.0351.0191.0220.9880.9891.0120.9921.0070.990.9960.9940.97651.33-92.7430.6750.61400.9350.9560.9490.927
EPS -3.77-6.5-7.3112.4812.23-8.5112.42-14.5111.6925.9616.356.28-0.91-1.850.440.51-2.492.522.641.621.38
EPS Diluted -3.77-6.46-7.3112.4812.23-8.5112.42-14.5111.6825.9516.356.28-0.91-1.850.440.51-2.492.52.641.621.38
EBITDA -206.528-356.025-404.741691.249677.499-470.186688.122-800.909653.0751,470.769932.968370.816-65.051-146.29437.43245.417-265.524297.284317.812202.846179.502
EBITDA Ratio 1.0351.0141.0220.9890.9891.010.9931.0060.9910.9960.9950.98451.262-92.7080.6890.61500.9350.9550.9490.928